Recent Diabetes related articles in the Big 4

Access
BMJ - current paper copy in library, electronic access 3 months delay - NHS Athens
Lancet - electronic access 2 months delay - NHS Athens
JAMA - current electronic access - NHS Athens
NEJM - current paper copy in library, partial electronic access to recent articles - no password, full text electronic access - 3 months delay - NHS Athens

CME: Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

EDITORIAL: UKPDS and the Legacy Effect
...Kingdom Prospective Diabetes Study (UKPDS) continues to produce important evidence concerning the evolution of type 2 diabetes and its management. Two studies published in this issue of the ...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

EARLY RELEASE: Immunotherapy on Trial for New-Onset Type 1 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

ORIGINAL ARTICLE: Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
...type 2 diabetes who had been assigned to tight or less-tight blood-pressure control revealed that benefits of previously improved control were not sustained when between-group blood-pressure differences equalized. Early improved blood-pressure control in patients with type 2 diabetes and hypertension was associated with a reduced risk of complic...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

EARLY RELEASE: GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
...type 1 diabetes mellitus. This trial assessed the ability of alum-formulated GAD (GAD-alum) to ...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

ORIGINAL ARTICLE: 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
...type 2 diabetes was sustained during 10 years of follow-up. Despite an early loss of glycemic differences, continued microvascular risk reduction and emergent risk reductions for myocardial infarction and death from any cause were observed.
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

CME: 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)

[Articles] Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
...type 2 diabetes. We compared the efficacy of a once-weekly formulation of exenatide to that of a twice daily dose.
The Lancet - Oct 3, 2008 10:48 AM

[Comment] Exenatide once weekly in type 2 diabetes
...type 2 diabetes have led to the need for additional treatments that can replace or be safely combined with existing agents. Patients with type 2 diabetes who have not achieved adequate glucose control at the maximum tolerated doses of their oral therapies have had no alternative other than insulin. However, the best insulin regimen is a matter o...
The Lancet - Oct 3, 2008 10:48 AM

CORRESPONDENCE: Intensive Glucose Control in Type 2 Diabetes
...Risk in Diabetes (ACCORD) study (June 12 issue),1 the intensive-therapy group ...
New England Journal of Medicine - Oct 1, 2008 10:54 PM

CME: Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 1, 2008 10:54 PM

ORIGINAL ARTICLE: Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
...type 1 diabetes mellitus who had glycated hemoglobin levels of 7.0 to 10.0% were stratified into three prespecified age groups and were assigned to receive continuous glucose monitoring or usual monitoring. The primary outcome was the change in glycated hemoglobin levels after 26 weeks. Continuous glucose monitoring was associated with improved ...
New England Journal of Medicine - Oct 1, 2008 10:54 PM

[PRACTICE] Early identification and management of chronic kidney disease: summary of NICE guidance
BMJ current issue - Sep 29, 2008 12:40 PM

[NEWS] Aboriginal children are still twice as likely to die as other young Australians
BMJ current issue - Sep 26, 2008 5:54 PM

[Articles] Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
...disease or diabetes with end-organ damage.
The Lancet - Sep 26, 2008 9:50 AM

[PRACTICE] Raised blood glucose concentration
BMJ current issue - Sep 25, 2008 12:46 PM

[NEWS] New reported risks add to concern about bisphenol A in plastics
BMJ current issue - Sep 24, 2008 10:44 AM

LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM

HEALTH AGENCIES UPDATE: Exenatide Risk
JAMA current issue - Sep 23, 2008 9:30 PM

LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women--Reply
JAMA current issue - Sep 23, 2008 9:30 PM

LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM

LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM

[RESEARCH] Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification
...diagnosis of diabetes; the WHO-ISH methods additionally included measurement of fasting blood glucose, total cholesterol, and creatinine, urinalysis, and electrocardiography. Main outcome measures Cardiovascular events and total deaths. Results With both methods there was a highly significant association between the level of predicted risk and ...
BMJ current issue - Sep 19, 2008 10:56 AM

[Case Report] No fire without smoke
...type 2 diabetes, and was taking isosorbide mononitrate, dipyridamole, aspirin, allopurinol, simvastatin, ferrous gluconate, furosemide, and gliclazide. She had never smoked.
The Lancet - Sep 19, 2008 10:32 AM

[Correspondence] Hyperglycaemia as a cardiovascular risk factor in diabetes
In their Seminar (May 24, p 1790), Ravi Retnakaran and Bernard Zinman argue, on the basis of the DCCT/EDIC Study, that hyperglycaemia is an important cardiovascular risk factor, and that hyperglycaemia early in the disease course might exert particular harm through “metabolic imprinting/memory”. Another study of intensive versus conventional treatm...
The Lancet - Sep 19, 2008 10:32 AM

ORIGINAL CONTRIBUTION: Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults
...associated with diabetes (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.21-1.60; P < .001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes -glutamyltransferase (OR per 1-SD increase in BPA concentr...
JAMA current issue - Sep 16, 2008 10:08 PM


[Series] Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care
...diabetes, and mental disorders is high in low-income and middle-income countries and is predicted to increase with the ageing of populations, urbanisation, and globalisation of risk factors. Furthermore, HIV/AIDS is increasingly becoming a chronic disorder. An integrated approach to the management of chronic diseases, irrespective of cause, is n...
The Lancet - Sep 12, 2008 10:26 AM